Please login to the form below

Not currently logged in
Email:
Password:

Anish Mehta appointed CEO of new women's health business

Will head up the former Teva portoflio CVC Capital Partners recently acquired

Anish MehtaLondon-based investment firm CVC Capital Partners has appointed Anish Mehta as chief executive officer of the international women’s health assets portfolio it acquired from Teva Pharmaceuticals last month.

Mehta joins from Allergan, where he was head of international business development leading the team responsible for corporate development and licensing activity in support of the international business.

He said: “I am honoured to have this opportunity to partner with CVC and the existing team to lead this exciting new business.

The combination of high quality products and a talented team creates a unique opportunity for us to build a leading, global, speciality pharmaceutical business dedicated to women’s health.”

Prior to his new role, Mehta has served at Actavis, taking the helm of its European and Middle East business, where he managed a portfolio of pharmaceutical products.

Cathrin Petty, partner and head of European Healthcare, CVC, said: “Anish is a well-established industry veteran, having spent over 20 years in the global healthcare space.

“His deep experience in M&A, complex carve outs and building businesses will be invaluable to us as we look to scale this business.”

19th October 2017

From: Sales

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Anthill Agency

Digital communications agency empowering clients through their digital transformation journey. Whether through training, delivering solutions or devising digital strategies, we...

Latest intelligence

Precision paediatrics: Treating patients with CAR-T
Dr Stuart Adams specialises in using T-cell therapy to treat paediatric patients at Great Ormond Street Hospital. Here, he explains what it was like to develop and deliver a groundbreaking...
What does it mean to be an agile organisation
We spoke with Philip Atkinson to learn how healthcare and pharmaceutical companies can rapidly respond to changes in the market....
Battling breast cancer with precision medicine (Part 2)
Dr Mark Moasser treated breast cancer survivor Laura Holmes-Haddad (interviewed in part one) with an innovative precision medicine, which at the time was yet to be approved. Here he gives...

Infographics